Session Information

Free Paper

[FP-TH-12] Medical Treatments of Glaucoma
Go back
print
Day
Apr 03 (Thu)
Time
15:30 - 17:00
Room
Room 13 - Tokyo International Forum 4F G402
Topic
Glaucoma
Chair/Coordinator
Chair)Norhafiza Razali、Chair)Vanessa Lemos、Chair)Tetsuya Yamamoto

Duration 5min, Q&A 3min

FP-TH-12-1 / 

Glaucoma

Anterior Ocular Surface and Prostaglandin without Preservatives Pros and Cons

Christina Grupcheva

Anterior Ocular Surface and Prostaglandin without Preservatives Pros and Cons

Duration 5min, Q&A 3min

FP-TH-12-2 / 

Glaucoma

Effect Of Topical Trans-Resveratrol on Retinal Ganglion Cell Counts and Redox Status in Rats with Steroid-Induced Ocular Hypertension

Norhafiza Razali

Effect Of Topical Trans-Resveratrol on Retinal Ganglion Cell Counts and Redox Status in Rats with Steroid-Induced Ocular Hypertension

Duration 5min, Q&A 3min

FP-TH-12-3 / 

Glaucoma

Are Prostaglandins Analogues Ineffective in Glaucoma Patients Who Uses Near Vision for Longer Duration of Time? Can Exercise Overcome This?

Bakht Samar Khan

Are Prostaglandins Analogues Ineffective in Glaucoma Patients Who Uses Near Vision for Longer Duration of Time? Can Exercise Overcome This?

Duration 5min, Q&A 3min

FP-TH-12-4 / 

Glaucoma

The Ocular Hypotensive Effect of Saffron Extract in Primary Open-Angle Glaucoma: A Pilot Study

Mohammad Hossein Jabbarpoor Bonyadi

The Ocular Hypotensive Effect of Saffron Extract in Primary Open-Angle Glaucoma: A Pilot Study

Duration 5min, Q&A 3min

FP-TH-12-5 / 

Glaucoma

Optimization of Consumed Volume of an Anti-Glaucoma Drug by Use of an Eyedroppimg Aid Device

Hiroshi Kobayashi

Optimization of Consumed Volume of an Anti-Glaucoma Drug by Use of an Eyedroppimg Aid Device

Duration 5min, Q&A 3min

FP-TH-12-6 / 

Glaucoma

Phase 3 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension

Tetsuya Yamamoto

Phase 3 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension

Duration 5min, Q&A 3min

FP-TH-12-7 / 

Glaucoma

Phase 3 Randomized Clinical Studies of a Rho Kinase Inhibitor, K-115, in Combination with Timolol or Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension

Hidenobu Tanihara

Phase 3 Randomized Clinical Studies of a Rho Kinase Inhibitor, K-115, in Combination with Timolol or Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension

Duration 5min, Q&A 3min

FP-TH-12-8 / 

Glaucoma

Penetration and Protective Effects of Exogenous Nmnat3 in High IOP-Induced Optic Nerve Degeneration

Yasushi Kitaoka

Penetration and Protective Effects of Exogenous Nmnat3 in High IOP-Induced Optic Nerve Degeneration

Duration 5min, Q&A 3min

FP-TH-12-9 / 

Glaucoma

Dock3 Protects Retinal Neurons in a Mouse Model of Normal Tension Glaucoma

Kazuhiko Namekata

Dock3 Protects Retinal Neurons in a Mouse Model of Normal Tension Glaucoma

Duration 5min, Q&A 3min

FP-TH-12-10 / 

Glaucoma

Raised Intraocular Pressure Following Intraviteal Triamcinolone Acetonide in Diabetic Versus Non-Diabetic Patients

Pir Salim Mahar

Raised Intraocular Pressure Following Intraviteal Triamcinolone Acetonide in Diabetic Versus Non-Diabetic Patients

Duration 5min, Q&A 3min

FP-TH-12-11 / 

Glaucoma

Effect on Intraocular Pressure in Patients Receiving Intravitreal Anti-Vascular Endotelial Growth Factor Injections

Vanessa Lemos

Effect on Intraocular Pressure in Patients Receiving Intravitreal Anti-Vascular Endotelial Growth Factor Injections

Go back